| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/27/2011 | CN102133238A Application of bacillus subtilis in antagonism helicobacter pylori |
| 07/27/2011 | CN102133236A Toad peptide antibiotics for preparing medicine for curing lung cancer |
| 07/27/2011 | CN102133235A Toad peptide antibiotics for preparing medicine for treating phthisis |
| 07/27/2011 | CN102133234A Application of bombesin antibiotic in preparation of medicines for treating gastric cancer |
| 07/27/2011 | CN102133231A Product prepared by shark cartilage for supplementing calcium and promoting metabolism and development of cartilage and preparation method thereof |
| 07/27/2011 | CN102133230A Compound mactra veneriformis organic calcium preparation and preparation method thereof |
| 07/27/2011 | CN102133200A Human relaxin-2 lyophilized powder preparation for injection |
| 07/27/2011 | CN101670115B Compound of heparanase and heat shock protein, preparation method and applications thereof |
| 07/27/2011 | CN101623503B Composite of survivin and sialylLewis and preparation method and application thereof |
| 07/27/2011 | CN101591348B Tetrahydrochysene carboline acyl aminoacid benzyl ester, preparation method and application thereof |
| 07/27/2011 | CN101497653B Small peptide for inhibiting solid tumor and leukaemia cancer cell growth and use thereof |
| 07/27/2011 | CN101463078B Exendin-4 derivative and solid phase chemical synthesis thereof |
| 07/27/2011 | CN101417126B New use of OMI protein and coding gene thereof |
| 07/27/2011 | CN101402681B Polypeptide from deer floral disc, preparing method and uses for preventing and treating diabetes |
| 07/27/2011 | CN101381405B Genetic engineering tumor targeting KCT-W1 polypeptides and preparation method and application |
| 07/27/2011 | CN101357227B Senile dementia recombinant adenovirus gene vaccine and preparation method thereof |
| 07/27/2011 | CN101249259B High content and high activity oral polysaccharide-peptide and preparing method and application of the same |
| 07/27/2011 | CN101208106B Cancer therapeutic agent |
| 07/27/2011 | CN101204579B Application of regrouped human minute plasminogen on process for preparing the medicine curing eye disorders |
| 07/27/2011 | CN101103108B HLA-binding peptides, DNA fragments encoding the same and recombinant vectors |
| 07/27/2011 | CN101062952B Fusion protein comprised of human serum and interferon and its coding gene and application |
| 07/26/2011 | US7985887 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2011 | US7985843 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/26/2011 | US7985839 Factor VIII polymer conjugates |
| 07/26/2011 | US7985838 Factor VIII polymer conjugates |
| 07/26/2011 | US7985836 Antimicrobial peptides and methods of identifying the same |
| 07/26/2011 | US7985835 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) |
| 07/26/2011 | US7985834 Compositions and methods for increasing bone mineralization |
| 07/26/2011 | US7985833 Collectin |
| 07/26/2011 | US7985832 Antimicrobial cathelicidin peptides |
| 07/26/2011 | US7985831 Crohn's disease antibody epitope peptide and reagent for testing Crohn's disease |
| 07/26/2011 | US7985771 Furanone derivatives |
| 07/26/2011 | US7985736 Therapeutic mixture comprising voltage gated calcium channel modulator for use in treatment and prevention of infertility, cancer, diabetes and behavioral disorders |
| 07/26/2011 | US7985735 mimetics of the activity of the N-terminal portion of Smac/tertiary binding structure to IAPs, can be combined with chemotherapeutic agents like topoisomerase inhibitors, kinase inhibitors, NSAIDs, taxanes and platinum containing compounds; increased cell permeability, water solubility; antitumor agents |
| 07/26/2011 | US7985734 Using immunogenic peptide for therapy of immunological liver damage or hepatotoxic chemical substance-induced liver damage, and Hepatitis C |
| 07/26/2011 | US7985733 Buffer-based method for preparing bivalirudin drug product |
| 07/26/2011 | US7985732 Unitary combination of FSH and hCG |
| 07/26/2011 | US7985731 Sugar chain added GLP-1 peptide |
| 07/26/2011 | US7985730 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 07/26/2011 | US7985729 Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis |
| 07/26/2011 | US7985728 Sustained release of Apo A-I mimetic peptides and methods of treatment |
| 07/26/2011 | US7985727 Apo A-I mimetic peptides and methods of treatment |
| 07/26/2011 | US7985726 ψεRACK peptide composition and method for protection against tissue damage due to ischemia |
| 07/26/2011 | US7985587 Methods of culturing dermal papilla cells |
| 07/26/2011 | US7985563 HIFαprolyl hydroxylation assay |
| 07/26/2011 | US7985411 Activatable recombinant neurotoxins |
| 07/26/2011 | US7985404 Reducing hair growth, hair follicle and hair shaft size and hair pigmentation |
| 07/26/2011 | US7985386 Implantable medical device for diagnostic sensing |
| 07/26/2011 | CA2784919A1 Compositions and methods relating to argininosuccinate synthetase |
| 07/26/2011 | CA2644467C Alpha crystalline form of perindopril arginine salt, its preparation process, and the pharmaceutical compositions that contain it |
| 07/26/2011 | CA2505937C Acetyl-l-carnitine for the prevention and/or treatment of peripheral neuropaties induced by anticancer agents |
| 07/26/2011 | CA2481325C Anti-hiv composition, production method thereof and medicament |
| 07/26/2011 | CA2461571C Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 07/26/2011 | CA2441225C A novel trp2 isoform containing hla-a2 restricted cytotoxic t lymphocyte epitopes |
| 07/26/2011 | CA2438851C Interleukin-18 mutants, their production and use |
| 07/26/2011 | CA2427655C Use of alpha adrenergic receptor agonist to reduce a decrease in neurosensory retinal function following laser therapy for choroidal neovascularization |
| 07/26/2011 | CA2405169C Devices and formulations |
| 07/26/2011 | CA2376346C Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 07/26/2011 | CA2352467C Apoptosis-inducing factor |
| 07/26/2011 | CA2334315C Compounds with growth hormone releasing properties |
| 07/26/2011 | CA2299677C Preparation and use of recombinant influenza a virus m2 constructs and vaccines |
| 07/26/2011 | CA2268331C Treatment of inner ear hair cells |
| 07/26/2011 | CA2222757C Modified/chimeric superantigens and their use |
| 07/26/2011 | CA2221409C Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
| 07/26/2011 | CA2215350C Transforming growth factor alpha hii |
| 07/21/2011 | WO2011088435A1 Methods for reducing protein levels in a cell |
| 07/21/2011 | WO2011088231A1 Apyrase therapy for bleeding conditions |
| 07/21/2011 | WO2011088210A1 Materials and methods related to sodium/potassium adenosine triphosphatase and src |
| 07/21/2011 | WO2011088196A2 Inhibitors of receptor tyrosine kinases (rtk) and methods of use thereof |
| 07/21/2011 | WO2011088123A2 Wnt antagonists and methods of treatment and screening |
| 07/21/2011 | WO2011088047A1 Soluble endoglin and uses thereof |
| 07/21/2011 | WO2011087869A1 Secreted protein acidic and rich in cysteine (sparc) protein srm/mrm assay |
| 07/21/2011 | WO2011087862A1 Insulin receptor substrate 1 (irs1) protein srm/mrm assay |
| 07/21/2011 | WO2011087768A1 Bmp-7 variants with reduced immunogenicity |
| 07/21/2011 | WO2011087672A1 Oxyntomodulin peptide analogue |
| 07/21/2011 | WO2011087671A1 Oxyntomodulin peptide analogue |
| 07/21/2011 | WO2011087102A1 Therapeutic agent for promoting recovery of animal under medical treatment |
| 07/21/2011 | WO2011087024A1 Insulin preparation |
| 07/21/2011 | WO2011087009A1 Regulatory gene controlling saccharometabolism, lipid metabolism, obesity and life, protein, and screening method |
| 07/21/2011 | WO2011086557A1 Peptides for the treatment of respiratory diseases |
| 07/21/2011 | WO2011086470A1 Treatment of multiple sclerosis |
| 07/21/2011 | WO2011086093A2 Pharmaceutical compositions for oral administration of insulin peptides |
| 07/21/2011 | WO2011085602A1 Protein hydrolysate, polypeptide solution and polypeptide, preparation method and use thereof |
| 07/21/2011 | WO2011085423A1 Cyclic peptides for the regulation of vectorial ion channels |
| 07/21/2011 | WO2011066372A9 Citrullination of human peptidylarginine deiminase 4 (pad-4) regulates its function and immunogenicity |
| 07/21/2011 | WO2011065867A3 Liposomes containing oligopeptide fragments of myelin basic protein, a pharmaceutical composition and a method for treatment of multiple sclerosis |
| 07/21/2011 | WO2011062762A3 Angiogenin and variants thereof for treatment of neurodegenerative diseases |
| 07/21/2011 | WO2011060372A3 Factor viii b cell epitope variants having reduced immunogenicity |
| 07/21/2011 | WO2011048387A3 Treatment of pre-term neonates |
| 07/21/2011 | WO2011035018A3 Suicide ready cells |
| 07/21/2011 | WO2011034919A3 Sh2 domain profiling to characterize tyrosine phosphorylation signaling in cancer |
| 07/21/2011 | WO2011034580A3 Small peptide modulators of potassium channel trafficking |
| 07/21/2011 | WO2011031884A3 Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides |
| 07/21/2011 | WO2011031477A3 Nucleolin-binding peptides, nucleolin-binding lytic peptides, fusion constructs and methods of making and using same |
| 07/21/2011 | WO2011029102A3 Cd117+cells and uses thereof |
| 07/21/2011 | WO2011028941A3 Disabling autophagy as a treatment for lysosomal storage diseases |
| 07/21/2011 | WO2011026041A9 Sdf-1 delivery for treating ischemic tissue |
| 07/21/2011 | WO2011026015A3 Stabilized melanocortin ligands |
| 07/21/2011 | WO2011022850A3 Uninterruptible power supply for a medical administration appliance |
| 07/21/2011 | WO2011011808A8 A cosmetic composition comprising sodium chloride in combination with one or more of protein, collagen, gelatin or amino acid |